BLK vs MRK: Which Is the Better Buy?
Side-by-side comparison of BlackRock, Inc. and Merck & Co., Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-21.
BlackRock, Inc. · Financial Services
$1,069.78
+44.0% upside to fair value
High Conviction
Grade A
High Quality
VS
Merck & Co., Inc. · Healthcare
$147.17
-4.1% upside to fair value
Med Conviction
Grade C
QuantHub Verdict
BLK has more upside to fair value
(+44.0%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
BLK |
MRK |
| Current Price |
$1,069.78 |
$147.17 |
| Fair Value Estimate |
$1,540.94 |
$141.07 |
| Upside to Fair Value |
+44.0%
|
-4.1%
|
| Market Cap |
$165.8B |
$363.5B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
15.9x
|
29.6x
|
| Price / Sales |
6.1x
|
5.5x
|
| Price / FCF |
71.5x
|
22.6x
|
| Revenue Growth YoY |
+30.6%
|
+5.1%
|
| Gross Margin |
55.7%
|
75.4%
|
| Operating Margin |
31.1%
|
16.7%
|
| Return on Equity |
11.7%
|
6.6%
|
| Dividend Yield |
2.09% |
2.31% |
| FCF Yield |
1.4%
|
4.42%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
BlackRock is the world's largest asset manager, overseeing $15.345 trillion in assets across ETFs, active strategies, alternatives, and the Aladdin investment-technology platform, serving institutional, intermediary, and individual clients globally. The business quality is high: TTM gross margin of 55.7%, operating margin of 31.1%, and net margin of 24.1% reflect the scalability of a fee-based mo…
Merck & Co., Inc. is a global healthcare leader with two core divisions, Pharmaceuticals and Animal Health, spanning oncology, vaccines, acute hospital care, immunology, neuroscience, virology, cardiovascular and diabetes, and it employs roughly 74,000 people under CEO Robert Davis. The business quality is medium: TTM gross margin of 75.4% and TTM operating margin of 16.7% reflect a genuinely hig…
Accumulation Zones
| Metric |
BLK |
MRK |
| Zone Low |
$1,155.70 |
$105.80 |
| Zone High |
$1,309.80 |
$119.91 |
| In Buy Zone? |
Yes
|
No
|